Mhamane et al., 2021 - Google Patents
Novel 1, 2, 3-triazole-tethered Pam3CAG conjugates as potential TLR-2 agonistic vaccine adjuvantsMhamane et al., 2021
- Document ID
- 17900403337160573636
- Author
- Mhamane T
- Sambyal S
- Vemireddy S
- Khan I
- Shafi S
- et al.
- Publication year
- Publication venue
- Bioorganic Chemistry
External Links
Snippet
A focused library of water soluble 1, 2, 3-triazole tethered glycopeptide conjugates derived from variety of azido-monosaccharides and aliphatic azido-alcohols were synthesized through manipulation at the C-terminus of Pam 3 CAG and screened for their potential as …
- 239000002671 adjuvant 0 title abstract description 28
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
- A61K47/48023—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent the modifying agent being an organic compound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU780577B2 (en) | Synthetic Lipid-A analogs and uses thereof | |
| Grigalevicius et al. | Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines | |
| Mhamane et al. | Novel 1, 2, 3-triazole-tethered Pam3CAG conjugates as potential TLR-2 agonistic vaccine adjuvants | |
| Reintjens et al. | Self-adjuvanting cancer vaccines from conjugation-ready lipid A analogues and synthetic long peptides | |
| KR102713536B1 (en) | Vaccine against Klebsiella pneumoniae | |
| Gobec et al. | Discovery of nanomolar desmuramylpeptide agonists of the innate immune receptor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) possessing immunostimulatory properties | |
| KR20150127030A (en) | Conjugate compounds | |
| AU2018361867B2 (en) | Brartemicin analogues | |
| Gobec et al. | Structural requirements of acylated Gly-l-Ala-d-Glu analogs for activation of the innate immune receptor NOD2 | |
| Yang et al. | Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development | |
| Chen et al. | Peptide-free synthetic nicotine vaccine candidates with α-galactosylceramide as adjuvant | |
| Nalla et al. | Design, synthesis and immunological evaluation of 1, 2, 3-triazole-tethered carbohydrate–Pam3Cys conjugates as TLR2 agonists | |
| CA3014515A1 (en) | Amino acid and peptide conjugates and conjugation process | |
| ES2267559T3 (en) | GLICOCONJUGADOS, GLICOAMINO, ACIDS ITS INTERMEDIARIES AND THE USE OF THE SAME. | |
| CN108367059A (en) | For the synthetic vaccine of S. pneumoniae serotypes 2 | |
| US9695208B2 (en) | Sialic acid (A-(2-6))-D-aminopyranose derivatives, synthesis methods and uses thereof | |
| Reddy et al. | Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants | |
| Abdu-Allah et al. | Design, synthesis and molecular docking study of α-triazolylsialosides as non-hydrolyzable and potent CD22 ligands | |
| JPWO2016104647A1 (en) | Glycoconjugate vaccine antigen and glycan introduction agent | |
| Shimoyama et al. | Chemical synthesis and immunomodulatory functions of bacterial lipid as | |
| Ding et al. | Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists | |
| EP2911698B1 (en) | Glycoconjugates and their use as potential vaccines against infection by shigella flexneri | |
| JP2022516837A (en) | Stable vaccine against Clostridium difficile | |
| Langenbach | Decorating Antigen with Multivalent CD22 Ligands to Prevent B-cell Mediated Anti-Drug Antibody Formation | |
| CN116056721A (en) | Adjuvants with TLR4 agonist activity |